Last update 03 Oct 2026

[111In]In-DOTA-ANTI-CEA antibody(Radboud University Medical Center)

Overview

Basic Info

Drug Type
Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC)
Synonyms-
Target
CEACAM5
Action
modulators
Mechanism
CEACAM5 modulators(Carcinoembryonic antigen related cell adhesion molecule 5 modulators)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Pancreatic Ductal AdenocarcinomaRectal Cancer
Originator Organization
Radboud University Medical CenterRadboud University Medical Center
Active Organization-
Inactive Organization
Radboud University Medical CenterRadboud University Medical Center
License Organization-
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

1
Clinical Trials associated with [111In]In-DOTA-ANTI-CEA antibody(Radboud University Medical Center)
NCT06395337
/ Unknown statusPhase 1/2IIT
A Phase I/II Study to Evaluate the Safety and Feasibility of Multimodal Imaging Using a Dual-labeled Anti-CEA Antibody in Patients With Rectal or Pancreatic Cancer
100 Clinical Results associated with [111In]In-DOTA-ANTI-CEA antibody(Radboud University Medical Center)
Login to view more data
100 Translational Medicine associated with [111In]In-DOTA-ANTI-CEA antibody(Radboud University Medical Center)
Login to view more data
100 Patents (Medical) associated with [111In]In-DOTA-ANTI-CEA antibody(Radboud University Medical Center)
Login to view more data
100 Deals associated with [111In]In-DOTA-ANTI-CEA antibody(Radboud University Medical Center)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatic Ductal AdenocarcinomaPhase 2
Netherlands
Radboud University Medical CenterRadboud University Medical Center
02 May 2024
Rectal CancerPhase 2
Netherlands
Radboud University Medical CenterRadboud University Medical Center
02 May 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free